Concepedia

Sabina B. Aleixo

SB

Statistics

Publications

4

Citations

90

H-Index

4

Active since

2012

Affiliations

Baylor College of Medicine(Current)

Boehringer Ingelheim (Brazil)

Hospital Moinhos de Vento

Boehringer Ingelheim (Germany)

Sabina B. Aleixo is an author at Baylor College of Medicine specializing in breast cancer, radiation oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2012–2018

4

Publications

4

A Neoadjuvant, Randomized, Open-Label Phase II Trial of Afatinib Versus Trastuzumab Versus Lapatinib in Patients With Locally Advanced HER2-Positive Breast Cancer

Mothaffar F. Rimawi, Sabina B. Aleixo, Ashley Alarcon Rozas et al. · Clinical Breast Cancer · 2014 · 40 citations

, , +4

Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study

Dae Ho Lee, Hiroshi Isobe, Hubert Wirtz et al. · BMC Health Services Research · 2018 · 28 citations · Full text

A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients

Roberto Hegg, André Mattar, João Nunes de Matos et al. · Clinics · 2016 · 12 citations · Full text

A neoadjuvant, randomized, open-label phase II trial of afatinib (A) versus trastuzumab (T) versus lapatinib (L) in patients (pts) with locally advanced HER2-positive breast cancer (BC).

Mothaffar F. Rimawi, Sabina B. Aleixo, Ashley Alarcon Rozas et al. · Journal of Clinical Oncology · 2012 · 10 citations

, , +14

1–4 of 4